Vijaya Diagnostic Centre Limited (VIJAYA.BO)
INR 1059.65
(-1.01%)
INR 1059.65
(-1.01%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 1.18 Billion INR | 40.4% |
| 2022 | 846.31 Million INR | -22.84% |
| 2021 | 1.09 Billion INR | 29.83% |
| 2020 | 844.78 Million INR | 35.08% |
| 2019 | 625.38 Million INR | 36.33% |
| 2018 | 458.74 Million INR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 313.45 Million INR | -6.29% |
| 2023 Q1 | 262.03 Million INR | -4.69% |
| 2023 Q2 | 333.22 Million INR | 27.17% |
| 2023 Q3 | 258.48 Million INR | -22.43% |
| 2023 FY | 1.18 Billion INR | 40.4% |
| 2023 Q4 | 334.5 Million INR | 29.41% |
| 2022 Q1 | 174.5 Million INR | -26.41% |
| 2022 FY | 846.31 Million INR | -22.84% |
| 2022 Q4 | 274.92 Million INR | 68.01% |
| 2022 Q3 | 163.63 Million INR | -29.85% |
| 2022 Q2 | 233.25 Million INR | 33.67% |
| 2021 Q2 | 277.11 Million INR | -15.95% |
| 2021 FY | 1.09 Billion INR | 29.83% |
| 2021 Q4 | 237.12 Million INR | -6.22% |
| 2021 Q3 | 252.86 Million INR | -8.75% |
| 2021 Q1 | 329.69 Million INR | 5.67% |
| 2020 Q1 | 19.13 Million INR | 0.0% |
| 2020 Q2 | 264.23 Million INR | 1281.24% |
| 2020 Q3 | 247.27 Million INR | -6.42% |
| 2020 FY | 844.78 Million INR | 35.08% |
| 2020 Q4 | 312.01 Million INR | 26.18% |
| 2019 FY | 625.38 Million INR | 36.33% |
| 2018 FY | 458.74 Million INR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Krsnaa Diagnostics Limited | 568.37 Million INR | -109.063% |
| Dr. Lal PathLabs Limited | 3.57 Billion INR | 66.784% |
| Metropolis Healthcare Limited | 1.27 Billion INR | 7.034% |
| Thyrocare Technologies Limited | 707.6 Million INR | -67.927% |
| Vimta Labs Limited | 410.09 Million INR | -189.754% |